Shannon Eagan, Patrick Gibbs and Tijana Brien from Cooley have stepped in to represent AcelRx Pharmaceuticals Inc., CEO Vincent J. Angotti and CFO Raffi Asadorian in a pending securities class action. The suit, for allegedly false claims about the risks of DSUVIA, medication for the treatment of acute pain, was filed June 8 in California Northern District Court by Pomerantz LLP. The case, assigned to U.S. District Judge Beth Labson Freeman, is 5:21-cv-04353, Sneed v. AcelRx Pharmaceuticals Inc. et al.

This suit was surfaced by Radar, a source for high-speed legal news and litigation updates personalized to your practice. Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.